Loading...
A123330 logo

Genic Co., Ltd.KOSDAQ:A123330 Stock Report

Market Cap ₩174.5b
Share Price
₩21.65k
₩574.44k
96.2% undervalued intrinsic discount
1Y-14.8%
7D-6.9%
Portfolio Value
View

Genic Co., Ltd.

KOSDAQ:A123330 Stock Report

Market Cap: ₩174.5b

Genic (A123330) Stock Overview

Researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. More details

A123330 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends0/6

A123330 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Genic Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genic
Historical stock prices
Current Share Price₩21,650.00
52 Week High₩44,100.00
52 Week Low₩15,570.00
Beta0.60
1 Month Change-32.34%
3 Month Change2.12%
1 Year Change-14.76%
3 Year Change354.83%
5 Year Change144.08%
Change since IPO-25.00%

Recent News & Updates

Analysis Article Feb 06

Genic Co., Ltd. (KOSDAQ:123330) Looks Just Right With A 42% Price Jump

Genic Co., Ltd. ( KOSDAQ:123330 ) shareholders would be excited to see that the share price has had a great month...

Recent updates

Analysis Article Feb 06

Genic Co., Ltd. (KOSDAQ:123330) Looks Just Right With A 42% Price Jump

Genic Co., Ltd. ( KOSDAQ:123330 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article Dec 04

These 4 Measures Indicate That Genic (KOSDAQ:123330) Is Using Debt Safely

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article Nov 03

Under The Bonnet, Genic's (KOSDAQ:123330) Returns Look Impressive

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...
Analysis Article Jul 15

Does Genic (KOSDAQ:123330) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Jun 16

A Look At The Fair Value Of Genic Co., Ltd. (KOSDAQ:123330)

Key Insights Genic's estimated fair value is ₩42,934 based on 2 Stage Free Cash Flow to Equity Genic's ₩41,750 share...
Analysis Article May 26

After Leaping 37% Genic Co., Ltd. (KOSDAQ:123330) Shares Are Not Flying Under The Radar

Genic Co., Ltd. ( KOSDAQ:123330 ) shares have had a really impressive month, gaining 37% after a shaky period...
Analysis Article May 23

Genic (KOSDAQ:123330) Is Very Good At Capital Allocation

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
Analysis Article Apr 09

Risks Still Elevated At These Prices As Genic Co., Ltd. (KOSDAQ:123330) Shares Dive 25%

To the annoyance of some shareholders, Genic Co., Ltd. ( KOSDAQ:123330 ) shares are down a considerable 25% in the last...
Analysis Article Mar 25

Genic's (KOSDAQ:123330) Earnings Aren't As Good As They Appear

Even though Genic Co., Ltd. ( KOSDAQ:123330 ) posted strong earnings recently, the stock hasn't reacted in a large way...
Analysis Article Jan 23

Genic (KOSDAQ:123330) Is Experiencing Growth In Returns On Capital

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysis Article Dec 26

Is Genic (KOSDAQ:123330) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Nov 29

Genic Co., Ltd.'s (KOSDAQ:123330) Popularity With Investors Under Threat As Stock Sinks 30%

The Genic Co., Ltd. ( KOSDAQ:123330 ) share price has softened a substantial 30% over the previous 30 days, handing...
Analysis Article Oct 10

There's Reason For Concern Over Genic Co., Ltd.'s (KOSDAQ:123330) Massive 34% Price Jump

Despite an already strong run, Genic Co., Ltd. ( KOSDAQ:123330 ) shares have been powering on, with a gain of 34% in...
Analysis Article Jul 27

Genic Co., Ltd.'s (KOSDAQ:123330) Share Price Not Quite Adding Up

There wouldn't be many who think Genic Co., Ltd.'s ( KOSDAQ:123330 ) price-to-sales (or "P/S") ratio of 0.8x is worth a...
Analysis Article Mar 12

Genic Co., Ltd.'s (KOSDAQ:123330) Shareholders Might Be Looking For Exit

With a median price-to-sales (or "P/S") ratio of close to 1x in the Personal Products industry in Korea, you could be...
Analysis Article Mar 19

Genic (KOSDAQ:123330) Is Making Moderate Use Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Dec 03

We Think Genic (KOSDAQ:123330) Has A Fair Chunk Of Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Shareholder Returns

A123330KR Personal ProductsKR Market
7D-6.9%-4.4%-0.6%
1Y-14.8%33.4%170.0%

Return vs Industry: A123330 underperformed the KR Personal Products industry which returned 33.4% over the past year.

Return vs Market: A123330 underperformed the KR Market which returned 170% over the past year.

Price Volatility

Is A123330's price volatile compared to industry and market?
A123330 volatility
A123330 Average Weekly Movement15.0%
Personal Products Industry Average Movement8.3%
Market Average Movement9.3%
10% most volatile stocks in KR Market16.6%
10% least volatile stocks in KR Market4.9%

Stable Share Price: A123330's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A123330's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2001324Heo Namwww.genic21.com

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands.

Genic Co., Ltd. Fundamentals Summary

How do Genic's earnings and revenue compare to its market cap?
A123330 fundamental statistics
Market cap₩174.49b
Earnings (TTM)₩18.89b
Revenue (TTM)₩78.20b
9.0x
P/E Ratio
2.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A123330 income statement (TTM)
Revenue₩78.20b
Cost of Revenue₩55.65b
Gross Profit₩22.55b
Other Expenses₩3.66b
Earnings₩18.89b

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.41k
Gross Margin28.83%
Net Profit Margin24.15%
Debt/Equity Ratio0%

How did A123330 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/18 11:46
End of Day Share Price 2026/05/18 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genic Co., Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Eun Jung ParkDaishin Securities Co. Ltd.
Na Young ParkDaiwa Securities Co. Ltd.
Choi Soon-HoEugene Investment & Securities Co Ltd.